Detalhe da pesquisa
1.
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Haematologica
; 106(12): 3079-3089, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179471
2.
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Br J Haematol
; 188(5): 605-622, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31621063
3.
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.
J Pathol
; 245(1): 61-73, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29464716
4.
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Blood Cancer J
; 13(1): 77, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173322
5.
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
Nat Med
; 29(3): 632-645, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928817
6.
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.
Cancers (Basel)
; 14(23)2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497281
7.
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.
Haematologica
; 96(10): 1470-7, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21685470
8.
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death.
Cancer Discov
; 11(5): 1268-1285, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355179
9.
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.
Sci Rep
; 11(1): 20745, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671057
10.
Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations.
Br J Haematol
; 171(1): 137-41, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25716545
11.
Simultaneous translocations of FGFR3/MMSET and CCND1 into two different IGH alleles in multiple myeloma: lack of concurrent activation of both proto-oncogenes.
Cancer Genet Cytogenet
; 175(1): 65-8, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17498561
12.
NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder.
Cancer Res
; 64(8): 2673-6, 2004 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15087377
13.
NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15).
Cancer Res
; 63(12): 3079-83, 2003 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12810632
14.
Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
Oncogene
; 22(7): 1070-2, 2003 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12592393
15.
Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
Oncogene
; 23(1): 311-6, 2004 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-14712237
16.
NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2.
Cancer Genet Cytogenet
; 157(2): 151-6, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15721637
17.
Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib.
Cancer Genet Cytogenet
; 160(1): 22-6, 2005 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15949566
18.
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.
Hematol J
; 5(6): 534-7, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15570299
19.
Lack of association of CYP3A4-V polymorphism with the risk of treatment-related leukemia.
Leuk Res
; 29(5): 595-7, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15755514
20.
Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion.
Cancer Genet Cytogenet
; 152(2): 177-8, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15262444